Hims & Hers Health (HIMS) Investment Thesis: Capturing Market Share in the Cash-Pay Space
Michigan-based investment advisor Cedar Grove Capital Management recently released its third-quarter 2026 investor letter. The letter can be downloaded here.
Posts Tagged ‘NYSE:HIMS’
What Is a SPAC? 10 Best SPACs to Invest In
Special purpose acquisition companies offer a route from private ownership to public markets without a conventional operating-company IPO.
Hims and Hers Is Scaling Rapidly, But Management Needs To Address The Difficult Questions
At first glance, Hims & Hers Health, Inc. (NYSE:HIMS) delivered the kind of result that investors typically reward.
Hims & Hers’ Australia Expansion Adds Growth, But Execution Will Be Key
Hims & Hers Health, Inc. (NYSE:HIMS) has entered Australia, marking its first expansion into the Asia-Pacific market.
Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company
On August 18, 2026, Hims & Hers Health, Inc.
Hims & Hers (HIMS)’ Weight-Loss Plans Results Penalties Over Visa (V) Credit Card Disputes
On August 21, 2026, Bloomberg reported that Hims & Hers Health, Inc. (NYSE:HIMS) was enrolled in Visa Inc.
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?
Hims & Hers Health, Inc.
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase?
We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best weight loss drugs on this list.
10 Best Weight Loss Drug Stocks to Buy in 2026
In this article, we will be taking a look at the 10 Best Weight Loss Drug Stocks to Buy in 2026.
10 Stocks Stealing the Spotlight from Wall Street Giants
Ten stocks started the trading week jumping by double-digits and mirroring the highly optimistic broader market, thanks to the US and Iran’s deal to end the war.
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
Is HIMS a good stock to buy? We came across a bearish thesis on Hims & Hers Health, Inc. on Valueinvestorsclub.com by Pridwen.
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2026 Earnings Call Transcript
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2026 Earnings Call Transcript May 11, 2026Hims & Hers Health, Inc. misses on earnings expectations.
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares.
10 Stocks With Monster Returns
Ten stocks boasted strong double- to triple-digit gains last week, outperforming a mostly optimistic US market amid US and Iran’s efforts for a peace deal.
Here’s How Cedar Grove Capital Management Benefitted from Its Short Position in Hims & Hers Health (HIMS)
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here.
10 Stocks With Unexpected Gains
Ten stocks kicked off the trading week with significant gains, mirroring Wall Street's broader optimism, as investors cheered strong US jobs data while waiting on the sidelines...
7 Best Stocks to Buy for Short Term
In this article, we will take a look at the best stocks to buy for the short term.
10 Stock Market Casualties You Can’t Ignore Today: UEC, Super Micro and More
Ten stocks fell sharply on Friday, with one falling to a new record low, as investors took path from a combination of macroeconomic uncertainties and corporate developments.
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on TopSecretStocks’s Substack by Simon.
Hims & Hers (HIMS) Soars 57.4% on New Deal
Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks Making Huge Moves this Week.
10 Stocks Making Huge Moves this Week: Fastly, Sasol, Hims and More
Ten stocks capped off the trading week delivering double-digit gains, despite the broader market suffering turmoil from the ongoing tensions in the Middle East.
Hims & Hers (HIMS) Sees Analyst Optimism Following Novo Resolution
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 11 Best Day Trading Stocks to Buy Now. Investment bank Barclays discussed Hims & Hers Health, Inc.
Barclays Raises PT on Hims & Hers Health (HIMS) Stock
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 12 Most Shorted Stocks to Buy in 2026.
12 Most Shorted Stocks to Buy in 2026
In this article, we will discuss the 12 Most Shorted Stocks to Buy in 2026.
Hims & Hers (HIMS) Soars 10.3% on Analyst Upgrades, New Deal
Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks Making Huge Moves Today.
10 Stocks Making Huge Moves Today
Ten stocks boasted strong gains on Wednesday amid a lackluster wider market, thanks to a flurry of corporate developments including partnerships, product launches, and analyst...
Barclays Lowers its Price Target on Hims & Hers Health, Inc. (HIMS) to $25 and Keeps an Overweight Rating
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 10 Fastest Growing NYSE Stocks to Buy. On February 24, 2026, Barclays lowered its price target on Hims & Hers Health, Inc.
10 Fastest Growing NYSE Stocks to Buy
In this article, we will look at the 10 Fastest Growing NYSE Stocks to Buy.
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny
Hims & Hers Health, Inc. (NYSE:HIMS) ranks among the most shorted stocks to buy according to analysts. Following Novo Nordisk’s lawsuit against Hims & Hers Health, Inc.
11 Most Shorted Stocks to Buy According to Analysts
In this article, we will take a look at the 11 Most Shorted Stocks to Buy According to Analysts.
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2025 Earnings Call Transcript
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2025 Earnings Call Transcript February 23, 2026Hims & Hers Health, Inc. beats earnings expectations.
Hims & Hers Health, Inc. (HIMS) Expands Global Footprint With Eucalyptus Acquisition
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Oversold Pharma Stocks to Buy Now. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the most oversold stocks.
7 Oversold Pharma Stocks to Buy Now
In this article, we will be taking a look at the 7 Oversold Pharma Stocks to Buy Now.
Do You Think Hims & Hers Health (HIMS) is Positioned for Long-Term Growth?
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”.
Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Hims & Hers Health, Inc.
15 Innovative Healthcare Stocks to Buy According to Analysts
In this article, we will be taking a look at the 15 Innovative Healthcare Stocks to Buy According to Analysts.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Edge’s Substack by David Vicuña. In this article, we will summarize the bulls’ thesis on HIMS.
BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Beauty Stocks to Buy Right Now.
7 Best Beauty Stocks to Buy Right Now
In this article, we will discuss: 7 Best Beauty Stocks to Buy Right Now.
Hims & Hers Health (HIMS) Fell Due to Increased Regulatory Challenges
Maple Tree Capital, an investment management company, released its Q3 2025 investor letter. A copy of the letter can be downloaded here.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares.
Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2025 Earnings Call Transcript
Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2025 Earnings Call Transcript November 3, 2025Hims & Hers Health, Inc. reports earnings inline with expectations.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on Business Ontology’s Substack by Lorenzo Bastianelli.
Hims & Hers (HIMS) Soars 16% as Firm On Track to Book $1 Billion Revenues from Women Segment
We recently published 10 Stocks Stealing Today’s Spotlight; 5 on All-Time Highs. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best performers on Wednesday.
Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives
We recently published 10 Hot Stocks Sparking Buying Frenzy. Hims & Hers Health Inc. (NYSE:HIMS) is one of the best performers on Tuesday.
16 Stocks Jim Cramer Recently Talked About
On Friday’s episode of Mad Money, host Jim Cramer commented on the sports betting industry, as he discussed how new competition from prediction markets is impacting the industry...
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on PatchTogether Investing’s Substack. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms
We recently published 10 Stocks Leaving the Market in the Dust. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best performers on Wednesday.
Truist Cuts Hims & Hers Health, Inc. (HIMS) Price Target, Cites Mixed Revenue Outlook
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best Russell 2000 stocks to buy now.
Hedge Fund Resource Center
